Clinical Trial Update: Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and efficacy of tissue plasminogen activator (alteplase) in neonates and infants with thrombosis; the study status is terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Drugs mentioned

• Tissue Plasminogen Activator (Alteplase) (Alteplase)

Snippet

Sponsor: University of Louisville | Conditions: Thrombosis | Phase 1 | Status: TERMINATED